Hematology-Oncology Associates of Northern New Jersey — Morristown, New Jersey

Hematology-Oncology Associates of Northern New Jersey is a clinical research site located in Morristown, New Jersey, United States 07962.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Hematology-Oncology Associates of Northern New Jersey has participated in 4 clinical trials.

Therapeutic areas: Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Sponsors: CTI BioPharma, Pfizer, Syndax Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology-Oncology Associates of Northern New Jersey?

Hematology-Oncology Associates of Northern New Jersey has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology-Oncology Associates of Northern New Jersey conducted?

Hematology-Oncology Associates of Northern New Jersey has 4 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Is Hematology-Oncology Associates of Northern New Jersey accredited by Crixeo Health?

Hematology-Oncology Associates of Northern New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology-Oncology Associates of Northern New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.